Clinical Trials Logo

Hereditary Coproporphyria clinical trials

View clinical trials related to Hereditary Coproporphyria.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02922413 Terminated - Clinical trials for Acute Intermittent Porphyria

Panhematin for Prevention of Acute Attacks of Porphyria

Start date: October 30, 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if Panhematin is safe and effective for prevention of acute attacks of porphyria. The study aims to provide high quality evidence for the use on hemin for prevention of acute attacks of porphyria. High quality studies have not been done previously for treating or preventing acute attacks with hemin. The lack of strong evidence for efficacy of hemin for treatment and prevention of attacks limits its availability for patients with acute porphyrias. Funding source: FDA Office of Orphan Product Development (FDA OOPD) FD-R-03720